Apple launches iPhone 18 Pro with upgrades

Apple has officially launched its newest smartphones, the iPhone 18 Pro and iPhone 18 Pro Max, introducing major upgrades to the camera, performance, battery life, and artificial intelligence.

Eli Lily’s weekly insulin cleared by FDA, opening a new front in diabetes care

On September 24th, the Food and Drug Administration (FDA) approved Eli Lilly and Company’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering millions of patients a potential alternative to daily long-acting insulin shots.

Nashville’s airport officially begins the process to be renamed after Dolly Parton

On September 11, 2026, the Metropolitan Nashville Airport Authority Board of Commissioners unanimously voted 6-0 to modify the facility’s naming policy, initiating the process of renaming Nashville International Airport in honor of Dolly Parton, a worldwide legend.

Nota speeds up robotic arm tasks with Qualcomm NPU

On September 22, AI model optimization company Nota announced that it had successfully adapted and optimized its robotics AI for Qualcomm’s Neural Processing Unit (NPU), tripling the operating speed of a robotic arm in real-world tests.

New York commemorates the 25th anniversary of 9/11 terror attacks with a memorial ceremony

The United States marked the 25th anniversary of the September 11, 2001, terrorist attacks on Friday with solemn memorial ceremonies held in New York, Washington, D.C., and Pennsylvania, honoring the nearly 3,000 people who lost their lives.

Generative AI reshapes Hollywood's labor market

In 2026, as traditional jobs in film and TV production decline, some writers, directors, and production staff are instead taking part in training AI systems.

How BookTok is changing the way Gen Z reads

Gen Z is reading more than any other generation in America right now.

FDA approves first mRNA vaccine for seasonal influenza

On August 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s mFlusiva (mRNA-1010), the first mRNA-based vaccine for seasonal influenza, for adults aged 50 and older.

New pancreatic cancer drug nearly doubles median survival

On August 26, 2026, the U.S. Food and Drug Administration approved daraxonrasib, a new targeted treatment for metastatic pancreatic cancer, following a Phase 3 trial that nearly doubled median overall survival compared with standard chemotherapy.

Lab-grown brain organoids follow human brain development for years

On August 19, 2026, Nature published a study showing that human cortical organoids, laboratory-grown models of the brain’s outer layer, can survive and continue developing for more than five years.